Metabolic phenotype and adipose and liver features in a high-fat western diet-induced mouse model of obesity-linked NAFLD

American Journal of Physiology - Endocrinology and Metabolism

Volumn 310, Issue 6, 2016, Pages E418-E439

  Luo, Yuwen ^a   Burrington, Christine M ^b   Graff, Emily C ^a   Zhang, Jian ^a   Judd, Robert L ^a   Suksaranjit, Promporn ^c   Kaewpoowat, Quanhathai ^c   Davenport, Samantha K ^c   O’Neill, Ann Marie ^a   Greene, Michael W ^a,b  

^a AUBURN UNIVERSITY   (United States)

^b BASSETT RESEARCH INSTITUTE   (United States)

^c BASSETT MEDICAL CENTER   (United States)

Author keywords

Adipose tissue; Fructose; High fat Western diet; Insulin resistance; NASH

Indexed keywords

ALANINE AMINOTRANSFERASE; COLLAGEN; COLLAGEN 1A2; COLLAGEN 3A1; FRUCTOSE; GLUCOSE; RECOMBINANT HUMAN INSULIN; SUCROSE; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ALPHA 2(I) COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN KINASE B; SUGAR INTAKE; TRANSCRIPTOME;

ADIPOCYTE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENERGY EXPENDITURE; FOOD INTAKE; GENE EXPRESSION; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HYPERPHAGIA; HYPERTROPHY; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; LIPID DIET; LIVER FIBROSIS; LIVER WEIGHT; MACROPHAGE; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; UPREGULATION; WESTERN DIET; WHITE ADIPOSE TISSUE; ANIMAL; C57BL MOUSE; DISEASE MODEL; FIBROSIS; GENETICS; IMMUNOBLOTTING; LIVER; METABOLISM; ORGAN SIZE; PATHOLOGY; PHENOTYPE; SUGAR INTAKE; WHITE ADIPOCYTE;

ADIPOCYTES, WHITE; ADIPOSE TISSUE, WHITE; ALANINE TRANSAMINASE; ANIMALS; COLLAGEN TYPE I; COLLAGEN TYPE III; DIET, HIGH-FAT; DIET, WESTERN; DIETARY SUCROSE; DISEASE MODELS, ANIMAL; FIBROSIS; FRUCTOSE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; HYPERPHAGIA; IMMUNOBLOTTING; INSULIN RESISTANCE; LIVER; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; ORGAN SIZE; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-AKT; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; TRIGLYCERIDES;

EID: 84983783142     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00319.2015     Document Type: Article

References (44)

1. Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ, Diehl AM. Nonalcoholic Steatohepatitis Clinical Research N. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology (Baltimore MD) 51: 1961–1971, 2010.
2. Almind K, Kahn CR. Genetic determinants of energy expenditure and insulin resistance in diet-induced obesity in mice. Diabetes 53: 3274–3285, 2004.
3. Charlton M, Krishnan A, Viker K, Sanderson S, Cazanave S, McConico A, Masuoko H, Gores G. Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. Am J Physiol Gastrointest Liver Physiol 301: G825–G834, 2011.
4. Dhingra R, Sullivan L, Jacques PF, Wang TJ, Fox CS, Meigs JB, D’Agostino RB, Gaziano JM, Vasan RS. Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation 116: 480–488, 2007.
5. Duffaut C, Galitzky J, Lafontan M, Bouloumie A. Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity. Biochem Biophys Res Commun 384: 482–485, 2009.
6. Duval C, Thissen U, Keshtkar S, Accart B, Stienstra R, Boekschoten MV, Roskams T, Kersten S, Muller M. Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57BL/6 mice. Diabetes 59: 3181–3191, 2010.
7. Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, Kechagias S. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology (Baltimore, MD) 44: 865–873, 2006.
8. Gastaldelli A, Harrison SA, Belfort-Aguilar R, Hardies LJ, Balas B, Schenker S, Cusi K. Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology (Baltimore, MD) 50: 1087–1093, 2009.
9. Gatselis NK, Ntaios G, Makaritsis K, Dalekos GN. Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease. Clin Exp Med 2013.
10. Gray SL, Nora ED, Grosse J, Manieri M, Stoeger T, Medina-Gomez G, Burling K, Wattler S, Russ A, Yeo GS, Chatterjee VK, O’Rahilly S, Voshol PJ, Cinti S, Vidal-Puig A. Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice. Diabetes 55: 2669–2677, 2006.
11. Halberg N, Khan T, Trujillo ME, Wernstedt-Asterholm I, Attie AD, Sherwani S, Wang ZV, Landskroner-Eiger S, Dineen S, Magalang UJ, Brekken RA, Scherer PE. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol 29: 4467–4483, 2009.
12. Hardy OT, Czech MP, Corvera S. What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabet Obes 19: 81–87, 2012.
13. Hoevenaars FP, Keijer J, Swarts HJ, Snaas-Alders S, Bekkenkamp- Grovenstein M, van Schothorst EM. Effects of dietary history on energy metabolism and physiological parameters in C57BL/6J mice. Exp Physiol 98: 1053–1062, 2013.
14. Ishimoto T, Lanaspa MA, Rivard CJ, Roncal-Jimenez CA, Orlicky DJ, Cicerchi C, McMahan RH, Abdelmalek MF, Rosen HR, Jackman MR, Maclean PS, Diggle CP, Asipu A, Inaba S, Kosugi T, Sato W, Maruyama S, Sanchez-Lozada LG, Sautin YY, Hill JO, Bonthron DT, Johnson RJ. High fat and high sucrose (western) diet induce steatohepatitis that is dependent on fructokinase. Hepatology (Baltimore, MD) 2013.
15. Jung Y, Diehl AM. Non-alcoholic steatohepatitis pathogenesis: role of repair in regulating the disease progression. Dig Dis 28: 225–228, 2010.
16. Kaiyala KJ, Spiekerman CF, Podolsky RH, McGuinness O. MMPC Energy Expenditure Analysis Page. https://www.mmpc.org/shared/regression.aspx.
17. Khan T, Muise ES, Iyengar P, Wang ZV, Chandalia M, Abate N, Zhang BB, Bonaldo P, Chua S, Scherer PE. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol 29: 1575–1591, 2009.
18. Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, Schraw T, Durand JL, Li H, Li G, Jelicks LA, Mehler MF, Hui DY, Deshaies Y, Shulman GI, Schwartz GJ, Scherer PE. Obesityassociated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117: 2621–2637, 2007.
19. Kohli R, Kirby M, Xanthakos SA, Softic S, Feldstein AE, Saxena V, Tang PH, Miles L, Miles MV, Balistreri WF, Woods SC, Seeley RJ. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology (Baltimore, MD) 52: 934–944, 2010.
20. Lighton JR, Turner RJ. The hygric hypothesis does not hold water: abolition of discontinuous gas exchange cycles does not affect water loss in the ant Camponotus vicinus. J Exp Biol 211: 563–567, 2008.
21. Machado MV, Michelotti GA, Xie G, de Almeida TP, Boursier J, Bohnic B, Guy CD, Diehl AM. Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease. PLoS One 10: e0127991, 2015.
22. Malhi H, Guicciardi ME, Gores GJ. Hepatocyte death: a clear and present danger. Physiol Rev 90: 1165–1194, 2010.
23. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47: 469–474, 1974.
24. Mehta K, Van Thiel DH, Shah N, Mobarhan S. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev 60: 289–293, 2002.
25. Parlee SD, Lentz SI, Mori H, MacDougald OA. Quantifying size and number of adipocytes in adipose tissue. Methods Enzymol 537: 93–122, 2014.
26. Parlee SD, Simon BR, Scheller EL, Alejandro EU, Learman BS, Krishnan V, Bernal-Mizrachi E, MacDougald OA. Administration of saccharin to neonatal mice influences body composition of adult males and reduces body weight of females. Endocrinology 155: 1313–1326, 2014.
27. Pendergast JS, Branecky KL, Yang W, Ellacott KL, Niswender KD, Yamazaki S. High-fat diet acutely affects circadian organisation and eating behavior. Eur J Neurosci 37: 1350–1356, 2013.
28. Qureshi K, Abrams GA. Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol 13: 3540–3553, 2007.
29. Reedy J, Krebs-Smith SM. Dietary sources of energy, solid fats, and added sugars among children and adolescents in the United States. J Am Diet Assoc 110: 1477–1484, 2010.
30. Rombouts K, Marra F. Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis. Dig Dis 28: 229–235, 2010.
31. Sarjeant K, Stephens JM. Adipogenesis. Cold Spring Harbor Perspect Biol 4: a008417, 2012.
32. Simon BR, Learman BS, Parlee SD, Scheller EL, Mori H, Cawthorn WP, Ning X, Krishnan V, Ma YL, Tyrberg B, MacDougald OA. Sweet taste receptor deficient mice have decreased adiposity and increased bone mass. PLoS One 9: e86454, 2014.
33. Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, Nakajima K, Nakano T, Beysen C, Hellerstein MK, Berglund L, Havel PJ. Consuming fructose-sweetened, not glucosesweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 119: 1322–1334, 2009.
34. Strissel KJ, DeFuria J, Shaul ME, Bennett G, Greenberg AS, Obin MS. T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity (Silver Spring, MD) 18: 1918–1925, 2010.
35. Sumiyoshi M, Sakanaka M, Kimura Y. Chronic intake of high-fat and high-sucrose diets differentially affects glucose intolerance in mice. J Nutr 136: 582–587, 2006.
36. Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest 121: 2094–2101, 2011.
37. Sun K, Tordjman J, Clement K, Scherer PE. Fibrosis and adipose tissue dysfunction. Cell Metab 18: 470–477, 2013.
38. Syn WK, Yang L, Chiang DJ, Qian Y, Jung Y, Karaca G, Choi SS, Witek RP, Omenetti A, Pereira TA, Diehl AM. Genetic differences in oxidative stress and inflammatory responses to diet-induced obesity do not alter liver fibrosis in mice. Liver Int 29: 1262–1272, 2009.
39. Tetri LH, Basaranoglu M, Brunt EM, Yerian LM, Neuschwander- Tetri BA. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol 295: G987–G995, 2008.
40. van Beek L, van Klinken JB, Pronk AC, van Dam AD, Dirven E, Rensen PC, Koning F, Willems van Dijk K, van Harmelen V. The limited storage capacity of gonadal adipose tissue directs the development of metabolic disorders in male C57Bl/6J mice. Diabetologia 58: 1601–1609, 2015.
41. Voigt A, Agnew K, van Schothorst EM, Keijer J, Klaus S. Short-term, high fat feeding-induced changes in white adipose tissue gene expression are highly predictive for long-term changes. Mol Nutr Food Res 57: 1423–1434, 2013.
42. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 109: 1–9, 1949.
43. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796–1808, 2003.
44. Welsh JA, Sharma A, Abramson JL, Vaccarino V, Gillespie C, Vos MB. Caloric sweetener consumption and dyslipidemia among US adults. JAMA 303: 1490–1497, 2010.